• Targeting protein trafficking pathways in melanoma 

      Guo, Dajiang
      Despite the recent breakthroughs in targeted drug- and immuno-therapies, late-stage melanoma patients still suffer from an abysmal prognosis due to development of drug resistance, enhanced toxicity and low response rates. ...
      USyd Access
      PhD Doctorate